Source: Annual Congress 2004 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. A. Ghofrani, F. Reichenberger, M. G. Kohstall, E. Mrosek, T. Seeger, W. Seeger, F. Grimminger (Giessen, Germany). Sildenafil increases exercise capacity by alleviation of hypoxic pulmonary hypertension at low altitude and at Mount Everest base camp. Eur Respir J 2004; 24: Suppl. 48, 760

Member's Comments

No comment yet.

Related content which might interest you: Exercise capacity and pulmonary circulation in sherpas vs aCCLimatized lowlanders at high altitude Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Estimation of effects of intermittent exposure to the altitude of 3200m on hypoxic pulmonary vasoreactivity Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004 Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude Source: Eur Respir J 2002; 20: Suppl. 38, 99s Year: 2002 High-altitude disease Source: Respipedia Article Year: 2017 Relationship of pulmonary arterial pressure at high altitude with oxygen saturation and exercise test Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Year: 2015 Pulmonary artery pressure limits exercise capacity at high altitude Source: Eur Respir J 2010; 36: 1049-1055 Year: 2010 Increased body weight and reduced vital capacity correlate with augmentation of pulmonary hypertension during intermittent hypoxia at an altitude of 3800 m according to five years‘ follow up Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Ventilatory exercise response at low altitude Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues Year: 2011 Travel to high altitude with pre-existing lung disease Source: Eur Respir J 2007; 29: 770-792 Year: 2007 Higher pulmonary artery pressure in children than in adults upon fast ascent to high altitude Source: Eur Respir J 2008; 32: 664-669 Year: 2008 Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Subclinical pulmonary oedma occurs on ascent to high altitude Source: Eur Respir J 2002; 20: Suppl. 38, 484s Year: 2002 Hypoxic ventilatory response in successful extreme altitude climbers Source: Eur Respir J 2006; 27: 165-171 Year: 2006 Development of animal model of high altitude pulmonary edema in exercising rats exposed to hypobaric hypoxia Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Pulmonary hypertension due to COPD at high altitude Source: Eur Respir J 2002; 20: Suppl. 38, 99s Year: 2002 Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude Source: Eur Respir J 2005; 25: 545-551 Year: 2005 Upper extremity aerobic exercise training improves peak oxygen consumption in patients with pulmonary arterial hypertension Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients Year: 2018 Prediction of the acute mountain sickness using SaO2 indices at rest and exercise in hypoxic conditions Source: Annual Congress 2011 - Work, the environment and respiratory disease Year: 2011